Solaris joins S&P SmallCap 600
Analysis based on 6 articles · First reported Jul 09, 2026 · Last updated Jul 09, 2026
The addition of Solaris Energy Infrastructure, Inc. to the S&P 600 may increase its visibility among index funds and passive investors. The removal of Catalyst Pharmaceuticals reflects its pending acquisition, which is a routine index adjustment.
Solaris Energy Infrastructure, Inc. Inc. will replace Catalyst Pharmaceuticals Inc. in the S&P 600 index, effective July 15, 2026. The change is driven by Angelini Pharma S.p.A.'s acquisition of Catalyst Pharmaceuticals, which is expected to close soon. S&P Dow Jones Indices announced the index rebalancing.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard